F

2021 ADA Highlights: SURPASS Program: Change in HbA1C From Baseline

By Francesco Giorgino 2 Videos
0 views
July 14, 2021
Comments 2
Login to view comments. Click here to Login

Featured Video

48:22
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…

Feat. B. Hirsch

Featured Video

46:20
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two In…

Feat. S. Shadid

Recommended

AUTOPLAY
34:49
Scripps Health

Medications for Weight Loss: The New Satiety Hormones

Feat. K. Fujioka
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

08:46
Robert Busch

FLOW Trial Results: GLPs, the Kidneys, and Even More to Come!!

12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

26:49
Diana Isaacs

Tirzepatide Updates

26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
20:24
Diana Isaacs

Tirzepatide for Type 2 Diabetes

44:41
Norman Lepor

Obesity: New Understanding and Treatments

06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

05:08
Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

09:44
Susan Brian

Mounjaro Update 2024

36:34
Scripps Health

GLP-1 Hysteria

Feat. S. Harris
23:35
Canadian Collaborative Research Network

Is Obesity Management the Next Frontier?

Feat. A. Michael Lincoff
11:07
Susan Brian

Wegovy 2024 Updates

38:07
Rodolfo Galindo

Diabesity: The True Pandemic of the XXI Century

49:21
McMaster University Department of Medicine

Semaglutide: Where Are We Now and Where Are We Going?

Feat. S. Boushahri, D. Lazzam, K. MacEachern
07:41
Susan Brian

Weightloss in Menopause

59:30
Scripps Health

Primary Care Literature Update: 2022/2023

Feat. J. Diamant
05:40
Susan Brian

An Introduction to Tirzepatide for Weightloss

13:33
Dr. Sharmila Ghimire

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesi…

Feat. D. Ghimire